PMC:7195088 / 22623-22874 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"679","span":{"begin":61,"end":69},"obj":"Species"},{"id":"946","span":{"begin":75,"end":93},"obj":"Disease"}],"attributes":[{"id":"A679","pred":"tao:has_database_id","subj":"679","obj":"Tax:9606"},{"id":"A946","pred":"tao:has_database_id","subj":"946","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T17","span":{"begin":183,"end":189},"obj":"Body_part"},{"id":"T18","span":{"begin":197,"end":203},"obj":"Body_part"},{"id":"T19","span":{"begin":207,"end":230},"obj":"Body_part"}],"attributes":[{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma228738"},{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma312401"},{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma45662"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T15","span":{"begin":183,"end":189},"obj":"Body_part"},{"id":"T16","span":{"begin":197,"end":203},"obj":"Body_part"},{"id":"T17","span":{"begin":207,"end":230},"obj":"Body_part"},{"id":"T18","span":{"begin":213,"end":230},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"},{"id":"A16","pred":"uberon_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/UBERON_0007311"},{"id":"A17","pred":"uberon_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"A18","pred":"uberon_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T26","span":{"begin":84,"end":93},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T109","span":{"begin":75,"end":83},"obj":"Disease"},{"id":"T110","span":{"begin":84,"end":93},"obj":"Disease"}],"attributes":[{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T110","span":{"begin":100,"end":105},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"},{"id":"T111","span":{"begin":207,"end":230},"obj":"http://purl.obolibrary.org/obo/UBERON_0001558"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T267","span":{"begin":16,"end":25},"obj":"Chemical"},{"id":"T268","span":{"begin":26,"end":36},"obj":"Chemical"},{"id":"T269","span":{"begin":100,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A267","pred":"chebi_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/CHEBI_367163"},{"id":"A268","pred":"chebi_id","subj":"T268","obj":"http://purl.obolibrary.org/obo/CHEBI_72291"},{"id":"A269","pred":"chebi_id","subj":"T269","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T5","span":{"begin":231,"end":241},"obj":"http://purl.obolibrary.org/obo/GO_0046903"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}

{"project":"LitCovid-sentences","denotations":[{"id":"T168","span":{"begin":95,"end":136},"obj":"Sentence"},{"id":"T169","span":{"begin":137,"end":251},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Comparison of darunavir/cobicistat vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04252274, recruiting). Primary endpoint: virologic clearance rate of throat swabs, sputum or lower respiratory tract secretions at day 7."}